Advion Evolution, New from Syngenta

Advion Evolution Cockroach Gel, is the high performing cockroach gel bait from Syngenta that delivers superior performance, even on bait-averse cockroach populations.


Advion Evolution Cockroach Gel is the latest in gel bait technology from Syngenta. New to the Australian pest control market, the enhanced formulation provides increased bait consumption and improved speed of kill, even when compared with Advion Cockroach Gel.1

The active ingredient in Advion Evolution Cockroach Gel is indoxacarb – meaning it offers similar benefits to the original Advion Cockroach Gel pest managers already know. Both Advion gels are non-staining, have no odour, don’t run, are non-repellent and come in an easy-to-use syringe. Advion Evolution is similarly labelled for indoor and outdoor use in residential, commercial and industrial sites.

The difference, however, is the new bait matrix, which has been developed to be even more attractive than the original Advion Cockroach Gel.

During testing, palatability trials with bait-averse German cockroaches showed that after 24 hours of exposure, 98 mg of Advion Evolution had been consumed compared with 39 mg of Advion Cockroach Gel – an increase in bait uptake of nearly 60% (pictured in chart below). As a consequence of the increased bait uptake, a much faster knockdown was recorded, with 100% mortality achieved after seven days for Advion Evolution compared with 81% for Advion Cockroach Gel after the same period.


Advion Evolution cockroach gel consumption chart


It’s the revised balance of sugars and proteins and the type of sugars used that has led to increased levels of attraction. This increased attraction and bait consumption ultimately leads to improved treatment outcomes.

Indoxacarb is a non-repellent active ingredient that is a type of a pro-insecticide, meaning it is bio-activated into an active insecticide only after it enters the cockroach’s body. Once the gel bait is ingested, the cockroach’s unique metabolic enzymes process the indoxacarb, and it becomes its active form.

Crucially, only insects have high enough concentrations of the metabolic enzymes needed for bio-activation to occur. This means non-target organisms, such as pets, are hardly impacted by the active ingredient. In most cases, they are not affected at all.

Advion Evolution has been demonstrated to give an increased speed of kill when compared to the original Advion Cockroach Gel. Again, focused on the challenging bait-averse strain, trials demonstrated that Advion Evolution had an LT90 (the time taking to kill 90% of the cockroach population) of 2.56 days, whereas Advion Cockroach Gel had a LT50 of 10.55 days.


Advion Evolution Cockroach Gel speed of kill chart


The new Advion Evolution cockroach gel gives pest managers a new tool to tackle German cockroach problems where bait adverse populations may be an issue, which is often the case in commercial accounts. Of course, in any account Advion Evolution is a great option when fast control is required. The original Advion Cockroach Gel is still a good choice for many standard cockroach treatments.

Like the original Advion Cockroach Gel, the indoxacarb in Advion Evolution helps deliver complete population control through tertiary kill. Teritary kill is a type of horizontal transfer of insecticide that occurs when insecticide is passed among individuals of the same population. Research has shown a primary donor can transfer an active ingredient to primary recipients, which then become secondary donors.

For example, the diagram below shows how a single adult cockroach can consume a lethal dose of indoxacarb, which in turn kills many nymphs (secondary mortality). These nymphs then become donors and can kill other cockroaches (tertiary kill).


Advion cockroach gel tertiary kill


With its new enhanced formulation, Advion Evolution has been developed to control even the toughest cockroaches.

Advion Evolution Cockroach Gel is available from distributors now.

More information on cockroach baits.


1 Syngenta PMP trial data submitted to the APVMA. Study ref USWP0I0532015